Literature DB >> 17433397

BJ-48, a novel thrombin-like enzyme from the Bothrops jararacussu venom with high selectivity for Arg over Lys in P1: Role of N-glycosylation in thermostability and active site accessibility.

Floriano P Silva-Junior1, Herbert L M Guedes, Laura C Garvey, Aniesse S Aguiar, Saulo C Bourguignon, Enrico Di Cera, Salvatore Giovanni-De-Simone.   

Abstract

BJ-48, a serine protease from the venom of Bothrops jararacussu, was purified to homogeneity using affinity chromatography on p-aminobenzamidine-agarose followed by HPLC gel filtration. BJ-48 presented 52kDa by SDS-PAGE analysis and 48,036Da by electron spray mass spectrometry. The enzyme was shown to be highly glycosylated with 42% of N-linked carbohydrates composed of Fuc(1):GalN(4):GlcN(5):Gal(1):Man(2) and a high content of sialic acid residues (8-12%). BJ-48 had optimal esterase activity at pH 7.5 and displayed maximum catalytic rate at 50 degrees C. Its hydrolytic activity was strongly inhibited by aprotinin and dithiothreitol while N-tosyl-l-phenylalanine chloromethyl ketone, 6-aminocaproic acid, E-64 and soybean trypsin inhibitor (SBTI) were ineffective. The kinetics of BJ-48 with chromogenic substrates revealed an unprecedented selectivity (10(4)-fold) for Arg over Lys in P1. BJ-48 proved to be a thrombin-like enzyme (TLE) with a specific fibrinogen-clotting activity of 73.4NIH units/mg. The TLE rapidly digested human fibrinogen Bbeta chain, but the Aalpha chain was cleaved specifically to release fibrinopeptide A with k(cat)/K(m)=2.1 microM(-1)s(-1). The TLE showed no activity toward other thrombin substrates like protein C, protease-activated receptor-1 or inhibitors such as hirudin and antithrombin. A non-denaturing procedure using PNGase F and neuraminidase followed by hydrophobic interaction chromatography was employed to obtain active BJ-48 forms with variable carbohydrate content. Compared to the native enzyme, total or partially deglycosylated BJ-48 forms presented up to 2-fold reduction in their specific activities upon heating at 55/65 degrees C or treatment with SBTI. These results point out a role for BJ-48 glycosylation in thermostability and controlling the access of some canonical protein inhibitors to the active site.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433397     DOI: 10.1016/j.toxicon.2007.02.018

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Rapid purification and procoagulant and platelet aggregating activities of Rhombeobin: a thrombin-like/gyroxin-like enzyme from Lachesis muta rhombeata snake venom.

Authors:  Frank Denis Torres-Huaco; Cláudio C Werneck; Cristina Pontes Vicente; Talita Vassequi-Silva; Ana Cláudia Coelho Nery-Diez; Camila B Mendes; Edson Antunes; Sérgio Marangoni; Daniela C S Damico
Journal:  Biomed Res Int       Date:  2013-08-24       Impact factor: 3.411

Review 2.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

Review 3.  Strategies for Heterologous Expression, Synthesis, and Purification of Animal Venom Toxins.

Authors:  Esperanza Rivera-de-Torre; Charlotte Rimbault; Timothy P Jenkins; Christoffer V Sørensen; Anna Damsbo; Natalie J Saez; Yoan Duhoo; Celeste Menuet Hackney; Lars Ellgaard; Andreas H Laustsen
Journal:  Front Bioeng Biotechnol       Date:  2022-01-20

4.  Small Angle X-ray Scattering, Molecular Modeling, and Chemometric Studies from a Thrombin-Like (Lmr-47) Enzyme of Lachesis m. rhombeata Venom.

Authors:  Salvatore Giovanni De-Simone; Guilherme Curty Lechuga; Paloma Napoleão-Pêgo; Larissa Rodrigues Gomes; David William Provance; Vinícius Dias Nirello; Ana Carolina Rennó Sodero; Herbert Leonel de Mattos Guedes
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

5.  Correlation between the glycan variations and defibrinogenating activities of acutobin and its recombinant glycoforms.

Authors:  Ying-Ming Wang; Inn-Ho Tsai; Jin-Mei Chen; An-Chun Cheng; Kay-Hooi Khoo
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

6.  The Procoagulant Snake Venom Serine Protease Potentially Having a Dual, Blood Coagulation Factor V and X-Activating Activity.

Authors:  Zorica Latinović; Adrijana Leonardi; Cho Yeow Koh; R Manjunatha Kini; Alenka Trampuš Bakija; Jože Pungerčar; Igor Križaj
Journal:  Toxins (Basel)       Date:  2020-05-29       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.